Medicare Enrolled
Dr. Yair Lotan, MD
Urology Physician · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lotan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lotan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lotan
Dr. Yair Lotan is an urology physician in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lotan performed 7,276 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lotan received a total of $340,776 from 51 pharmaceutical and/or device companies across 286 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lotan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in TX
$340,776 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,276
Medicare services
Top 14% in TX for urology physician
Not available
Unique patients (not deduplicated)
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,831 | $2 | $10 |
| Injection, docetaxel, 1 mg | 1,800 | $0 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
711 | $91 | $344 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
450 | $178 | $837 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
340 | $3 | $18 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 296 | $3 | $395 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 144 | $135 | $2,030 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
112 | $67 | $468 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
101 | $62 | $232 |
| Hexaminolevulinate hydrochloride instillation, 100 mg Instillation of hexaminolevulinate hydrochloride, 100 mg. |
69 | $962 | $4,405 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
57 | $134 | $464 |
| New patient office visit, complex (60-74 min) | 55 | $151 | $664 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $110 | $533 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
38 | $8 | $80 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
31 | $53 | $138 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
29 | $61 | $234 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $109 | $2,442 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
24 | $25 | $143 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $41 | $140 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
23 | $199 | $1,356 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
18 | $605 | $3,724 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
17 | $76 | $212 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
15 | $10 | $340 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
12 | $58 | $346 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
29.7% medium
70.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$340,776
Total received (2018-2024)
Avg $48,682/year across 7 years
Top 1% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
286
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$63,838
2023
$30,228
2022
$59,973
2021
$41,185
2020
$51,729
2019
$61,283
2018
$32,541
Payments by company (2024)
UROGEN PHARMA, INC.
$25,809
Photocure Inc
$18,634
Merck Sharp & Dohme LLC
$7,872
PFIZER INC.
$4,406
Janssen Biotech, Inc.
$3,330
AstraZeneca Pharmaceuticals LP
$1,074
Ferring Pharmaceuticals Inc.
$935
Janssen Scientific Affairs, LLC
$818
Teleflex LLC
$161
Antares Pharma, Inc.
$134
Myriad Genetic Laboratories, Inc.
$121
Novartis Pharmaceuticals Corporation
$115
Astellas Pharma Global Development
$104
Medtronic, Inc.
$78
Cook Medical LLC
$73
IMMUNITYBIO, INC.
$57
Olympus America Inc.
$51
Innovation Technologies Inc
$49
Tolmar, Inc.
$17
Top 3 companies account for 81.9% of 2024 payments
All-time payments by company (2018-2024) ›
Photocure Inc
$116,606
UroGen Pharma, Inc.
$38,659
UROGEN PHARMA, INC.
$36,009
Ambu Inc.
$33,577
Merck Sharp & Dohme Corporation
$26,093
Merck Sharp & Dohme LLC
$17,344
AstraZeneca Pharmaceuticals LP
$12,247
Ipsen Innovation
$7,711
Verity Pharmaceuticals Inc.
$7,377
E.R. Squibb & Sons, L.L.C.
$7,112
PFIZER INC.
$5,921
Ferring Pharmaceuticals AS
$5,642
Seagen Inc.
$4,484
Ipsen Pharma SAS
$4,425
Janssen Biotech, Inc.
$3,330
Nonagen Bioscience Corp
$2,625
Blue Earth Diagnostics Limited
$2,258
Ferring Pharmaceuticals Inc.
$2,050
UroViu Corporation
$1,580
Janssen Scientific Affairs, LLC
$913
Intuitive Surgical, Inc.
$515
AbbVie Inc.
$500
Profound Medical Corp.
$430
Medtronic, Inc.
$357
PROCEPT BioRobotics Corporation
$322
Novartis Pharmaceuticals Corporation
$276
Dendreon Pharmaceuticals LLC
$228
EDAP TECHNOMED INC
$195
CONMED Corporation
$189
Teleflex LLC
$161
AngioDynamics, Inc.
$143
Myovant Sciences Inc.
$138
Antares Pharma, Inc.
$134
AVEO Pharmaceuticals, Inc.
$132
Boston Scientific Corporation
$131
Myriad Genetic Laboratories, Inc.
$121
TOLMAR Pharmaceuticals, Inc.
$109
Astellas Pharma Global Development
$104
Foundation Medicine, Inc.
$100
EMD Serono, Inc.
$95
Cook Medical LLC
$73
Genentech, Inc.
$57
IMMUNITYBIO, INC.
$57
Olympus America Inc.
$51
Innovation Technologies Inc
$49
Rochester Medical Corporation
$41
KARL STORZ Endoscopy-America
$26
Supernus Pharmaceuticals, Inc.
$25
Janssen Research & Development, LLC
$21
Tolmar, Inc.
$17
Astellas Pharma US Inc
$14
Top 3 companies account for 56.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AMS 800 Artificial Urinary Sphincter · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Axumin · BALVERSA · BAVENCIO · CCU · CYSVIEW · Cysview · Da Vinci Surgical System · ELIGARD · ERLEADA · FOTIVDA · FOUNDATIONONE · GENERAL THERAPIES · IMAGE1 CONNECT · IMFINZI · INTERSTIM · IRRISEPT · JATENZO · JELMYTO · KEYTRUDA · LUTATHERA · LYNPARZA · MODULAR · MYRBETRIQ · NANOKNIFE · OPDIVO · ORGOVYX · Oncuria · PADCEV · PLUVICTO · PROLARIS · PROVENGE · RESONANCE · TALZENNA · Trelstar · Tulsa-Pro · US · Uro-G Flexible Cystoscope · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
155
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lotan is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lotan experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Lotan performed 2,831 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lotan receive payments from pharmaceutical companies?
Yes. Dr. Lotan received a total of $340,776 from 51 companies across 286 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lotan's costs compare to other urology physicians in Dallas?
Dr. Lotan's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lotan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Dallas
Browse urology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Photocure Inc Payments to Doctors
See all physicians who received payments from Photocure Inc.
By company
UroGen Pharma, Inc. Payments to Doctors
See all physicians who received payments from UroGen Pharma, Inc.
By company
UROGEN PHARMA, INC. Payments to Doctors
See all physicians who received payments from UROGEN PHARMA, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology